|
|
Article: Acrongenomics Inc. Appoints De Facto Communications to Provide Public & Investor Relations Services.
- Article from:
- Business Wire
- Article date:
- January 3, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
GENEVA -- Acrongenomics Inc. (OTCBB:AGNM) announces today that it has appointed London based De Facto Communications to manage its public and investor relations from January 2008. De Facto's appointment is a key part of the strategy to finalise the development and commercialisation of the point-of-care diagnostic device that the Company is in the process of fully acquiring. De Facto's role will be to continue to build the reputation of Acrongenomics with all stakeholders in Europe and North America as the Company completes its acquisition of Molecular Vision Limited and moves towards earning its first revenues.
In November 2007, Acrongenomics Inc. announced that ...